AstraZeneca obesity pill helps patients lose 10.5% of body weight in trial
- Posted on June 8, 2026
- By Bing News
- 0 Views
- 1 min read
AstraZeneca obesity pill helps patients lose 10.5% of body weight in trial
By Maggie Fick LONDON, June 8 (Reuters) - AstraZeneca said on Monday that patients lost 10.5% of their body weight after 26 weeks in a mid-stage trial of its experimental obesity pill, as the drugmaker seeks to challenge Novo Nordisk and Eli Lilly in the fast-growing weight-loss market. The company said the weight loss continued over time and that adults with obesity or overweight receiving the
